BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11077984)

  • 1. Mechanisms of vanadium action: insulin-mimetic or insulin-enhancing agent?
    Cam MC; Brownsey RW; McNeill JH
    Can J Physiol Pharmacol; 2000 Oct; 78(10):829-47. PubMed ID: 11077984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
    Srivastava AK; Mehdi MZ
    Diabet Med; 2005 Jan; 22(1):2-13. PubMed ID: 15606684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin signal mimicry as a mechanism for the insulin-like effects of vanadium.
    Mehdi MZ; Pandey SK; Théberge JF; Srivastava AK
    Cell Biochem Biophys; 2006; 44(1):73-81. PubMed ID: 16456236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The insulin-like properties of vanadium: a curiosity or a perspective for the treatment of diabetes?
    Brichard SM; Lederer J; Henquin JC
    Diabete Metab; 1991; 17(5):435-40. PubMed ID: 1752343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research.
    Sekar N; Li J; Shechter Y
    Crit Rev Biochem Mol Biol; 1996 Dec; 31(5-6):339-59. PubMed ID: 8994801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats.
    Cam MC; Brownsey RW; Rodrigues B; McNeill JH
    Metabolism; 2001 Jun; 50(6):674-80. PubMed ID: 11398144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
    Burén J; Lindmark S; Renström F; Eriksson JW
    Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
    Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
    Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanadium compounds as insulin mimics.
    Orvig C; Thompson KH; Battell M; McNeill JH
    Met Ions Biol Syst; 1995; 31():575-94. PubMed ID: 8564818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
    Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
    Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arylalkylamine vanadium salts as new anti-diabetic compounds.
    Zorzano A; Palacín M; Marti L; García-Vicente S
    J Inorg Biochem; 2009 Apr; 103(4):559-66. PubMed ID: 19246098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice.
    Mueller AS; Pallauf J
    J Nutr Biochem; 2006 Aug; 17(8):548-60. PubMed ID: 16443359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vanadium on insulin sensitivity and appetite.
    Wang J; Yuen VG; McNeill JH
    Metabolism; 2001 Jun; 50(6):667-73. PubMed ID: 11398143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimesis.
    Mehdi MZ; Srivastava AK
    Arch Biochem Biophys; 2005 Aug; 440(2):158-64. PubMed ID: 16055077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new concept: the use of vanadium complexes in the treatment of diabetes mellitus.
    Sakurai H
    Chem Rec; 2002; 2(4):237-48. PubMed ID: 12203906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin-like effects of vanadium and other metallic ions. Potential use in the treatment of diabetes].
    Chiasson JL; Srivastava AK
    Journ Annu Diabetol Hotel Dieu; 1999; ():201-11. PubMed ID: 10732418
    [No Abstract]   [Full Text] [Related]  

  • 20. The potential biological mechanisms of arsenic-induced diabetes mellitus.
    Tseng CH
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):67-83. PubMed ID: 15163543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.